Arine is a leading AI-powered medication optimization platform that improves patient outcomes and reduces healthcare costs by ensuring that patients receive the most effective and appropriate medications. By integrating advanced analytics with deep clinical expertise, Arine provides timely, personalized recommendations, enabling health plans and at-risk provider organizations to enhance medication safety, adherence, and effectiveness among their members.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 06/24/25 | $30,000,000 | Series C |
Kaiser Permanente Ventures Town Hall Ventures  | undisclosed |
